Surging global demand for high-affinity affinity-binding ligands, expanding applications of synthetic oligonucleotide alternatives to monoclonal antibodies, and continuous biopharmaceutical innovations in Systematic Evolution of Ligands by Exponential Enrichment (SELEX) are driving rapid growth across the global Aptamers Market. Aptamers—comprising DNA and RNA aptamers, chemically...
